Category: Insights for investors
)
How we achieved MDR IIb certification: The Infermedica story
Discover Infermedica’s journey to MDR Class IIb certification. Learn how we navigated the complexities of AI regulation in healthcare, overcame key challenges, and built trust through safety, compliance, and clinical validation.
)
Not all AI is created equal. We’ve got MDR Class IIb certification.
Building trust in healthcare AI: our Medical Guidance Platform is now MDR Class IIb certified, the highest level for software of its kind.
)
Infermedica 2024: Year in review
Discover amazing insights into Infermedica’s achievements in 2024, including innovations in product and peer-reviewed research into virtual triage
)
Diversity in action: Celebrating women in leadership at Infermedica!
This article explores the landscape of female leaders at Infermedica, highlighting their journeys and showing their advice for future women in tech.
)
Revolutionizing Healthcare Engagement: Infermedica and Talkdesk Announce Partnership
Empowering healthcare providers to navigate patients to the most suitable care, enhancing automation, patient decision-making, and access
)
Infermedica 2023: Year in review
A reflection of Infermedica's achievements in 2023 and a look ahead to 2024.
)
How Infermedica helps digitize healthcare regions in Germany
The Bavarian Spas Association (BHV) users can now analyze their symptoms and get connected to regional healthcare offerings with Infermedica solutions.
)
Infermedica expands company’s API capabilities to include AI-driven patient intake workflows
We are happy to introduce our new API for Intake, which improves patient care, reduces clinician burnout, and delivers intake data prior to care.
)
Infermedica 2022: Year in Review
A roundup of what we’ve accomplished in 2022, and what’s next in 2023.
)
Techniker Krankenkasse launches Infermedica’s symptom checker
A German health insurer expands its offer with a symptom checker, a new tool based on Infermedica Triage, to empower its members.
)
Infermedica named to the 2022 CB Insights’ Digital Health 150 List
We’re pleased to announce that CB Insights named Infermedica to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.
)
Infermedica partners with conversational AI company Hyro to support patient triage
The partnership enables healthcare organizations to support patients by utilizing the Medical Guidance Platform and Hyro’s natural language understanding engine
)